# Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

> **NCT05842408** · PHASE3 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 384 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** DA-5212
- **DRUG:** DA-5212-R

## Key facts

- **NCT ID:** NCT05842408
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-06
- **Primary completion:** 2024-09-04
- **Final completion:** 2024-09-04
- **Target enrollment:** 384 (ACTUAL)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05842408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05842408, "Clinical Trial of DA-5212 in Patients with Functional Dyspepsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05842408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*